Insiders · Profile

Finegan Michael

Chief Strategy Officer at Orthofix Medical. Filing since 2 Aug 2012. CIK 0001391402

Company
Date
Role
Action
Shares
Amount
Of holding
5 Jun 2020
Chief Strategy Officer
Sold, plan not stated
8,750
$327.32K
15.4%
18 Jun 2018
Chief Strategy Officer
Sold, plan not stated
30,000
$1.76M
44.9%
1 Sep 2016
Chief Strategy Officer
Sold, plan not stated
25,000
$1.13M
37.5%
18 Apr 2016
Chief Strategy Officer
Sold, plan not stated
28,750
$1.27M
42.6%
14 Apr 2016
Chief Strategy Officer
Sold, plan not stated
52,222
$2.19M
57.4%
11 Nov 2015
Chief Strategy Officer
Sold, plan not stated
14,140
$593.88K
19.5%
16 Aug 2012
President, Biologics
Bought
3,000
$123.60K
14.4%
15 Aug 2012
President, Biologics
Sold, plan not stated
7,000
$287.01K
22.7%
10 Aug 2012
President, Biologics
Sold, plan not stated
10,000
$417.84K
29.5%
3 Aug 2012
President, Biologics
Sold, plan not stated
11,700
$489.48K
32.9%
2 Aug 2012
President, Biologics
Sold, plan not stated
3,300
$135.36K
12.2%
11 decisions on file.